MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer

Joonwoo Park1, Ga Hee Kim2, Jeonggeun Lee1

  • 1Department of Integrative Bioscience and Biotechnology, College of Life Science, Sejong University, Kwangjin-gu, Seoul 05006, South Korea.

Insights

Mammalian sterile 20-like kinase 2 (MST2) suppresses estrogen receptor-positive breast cancer growth by promoting apoptosis and inhibiting cell viability. Low MST2 expression correlates with better survival in these patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mammalian sterile 20-like kinase 1/2 (MST1/2) are key regulators of cell growth and apoptosis, acting as tumor suppressors.
  • Previous studies indicated MST2 overexpression activates Estrogen Receptor alpha (ERα) in ER-positive breast cancer cells.
  • The precise role of MST2 in ER-positive breast cancer progression requires further elucidation.

Purpose of the Study:

  • To investigate the role of MST2 in the proliferation and progression of ER-positive human breast cancer MCF-7 cells.
  • To evaluate the therapeutic potential of targeting MST2 in ER-positive breast cancer.

Main Methods:

  • In vitro assays including cell cycle, apoptosis, and mammosphere formation were used to assess MST2 ablation effects.
  • In vivo studies utilized a tumor-bearing mouse model treated with MST2-siRNA.
  • Kaplan-Meier plotter analysis of public datasets examined MST2's impact on overall survival in breast cancer patients.

Main Results:

  • MST2 ablation significantly suppressed MCF-7 cell viability, induced caspase-dependent apoptosis, and reduced mammosphere formation.
  • MST2 knockdown did not affect ER-negative MDA-MB-231 cells, highlighting ER-dependency.
  • In vivo, MST2-siRNA treatment inhibited tumor growth, with further reduction observed when combined with tamoxifen.

Conclusions:

  • MST2 plays a critical role in promoting ER-positive breast cancer cell growth and progression.
  • Targeting MST2, a component of the Hippo signaling pathway, represents a potential therapeutic strategy for ER-positive breast cancer.
  • Low MST2 expression is associated with improved overall survival in ER-positive breast cancer patients.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.3K